Cargando…

Managing rheumatic diseases during COVID-19

Rheumatology practice, during Coronavirus Disease 2019 (COVID-19) pandemic, has faced multifaceted challenges. Rheumatologists routinely prescribe immunosuppressant medications to their patients with multisystem autoimmune rheumatic diseases who are concerned about the increased risk of acquiring CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladani, Amit P., Loganathan, Muruga, Danve, Abhijeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476772/ https://www.ncbi.nlm.nih.gov/pubmed/32895747 http://dx.doi.org/10.1007/s10067-020-05387-8

Ejemplares similares

Beware of Chilaiditi sign!!
por: Danve, Abhijeet, et al.
Publicado: (2015)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic
por: Akintayo, Richard Oluyinka, et al.
Publicado: (2020)

Non-ketotic hyperglycemia unmasks hemichorea
por: Danve, Abhijeet, et al.
Publicado: (2015)

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases
por: Boyadzhieva, Vladimira Vasileva, et al.
Publicado: (2020)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
por: Ahmed, Sakir, et al.
Publicado: (2021)

Rheumatic disease and COVID-19: epidemiology and outcomes
por: Hyrich, Kimme L., et al.
Publicado: (2020)

Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic
por: Seo, Mi Ryoung, et al.
Publicado: (2020)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022)

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic
por: Mukusheva, Zaure, et al.
Publicado: (2020)

Long COVID in autoimmune rheumatic diseases
por: Fedorchenko, Yuliya, et al.
Publicado: (2023)

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Management of atrial fibrillation in rheumatic heart disease
por: Shenthar, Jayaprakash
Publicado: (2022)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases
por: Jara, Luis J., et al.
Publicado: (2021)

Smartphone APPlications in the clinical care and management of Rheumatic Diseases
por: Salaffi, Fausto, et al.
Publicado: (2018)

Comprehensive Management of Rheumatic Diseases Affecting the Temporomandibular Joint
por: Covert, Lauren, et al.
Publicado: (2021)

The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
por: Molina Collada, Juan, et al.
Publicado: (2021)

Incidence of rheumatic diseases during the COVID-19 pandemic in South Korea
por: Ahn, Soo Min, et al.
Publicado: (2023)

The Rheumatic Diseases
Publicado: (1950)

The Rheumatic Diseases
Publicado: (1945)

Rheumatic Disease-Related Symptoms During the Height of the COVID-19 Pandemic
por: Mancuso, Carol A., et al.
Publicado: (2020)

There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia
por: Williamson, Joseph, et al.
Publicado: (2021)

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
por: Grainger, Rebecca, et al.
Publicado: (2022)

Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19
por: Cutolo, Maurizio, et al.
Publicado: (2023)

COVID-19 and the clinical course of rheumatic manifestations
por: Ahmed, Sakir, et al.
Publicado: (2021)

Rheumatic Disease Patients with COVID-19 Diagnosis
por: Treadwell, Edward L.
Publicado: (2020)

COVID-19 with rheumatic diseases: a report of 5 cases
por: Cheng, Chuanfang, et al.
Publicado: (2020)

Role of Dual Energy Computed Tomography Imaging in the Diagnosis of Gout
por: Jayakumar, Divya, et al.
Publicado: (2017)

Impact of COVID-19 on management of urogynaecology patients: a rapid review of the literature
por: Loganathan, Jemina, et al.
Publicado: (2021)

Clinical and Diagnostic Considerations for Atypical, Adult Onset Presentation of Chronic Recurrent Multifocal Osteomyelitis (CRMO)
por: Mahady, Stacey, et al.
Publicado: (2019)

Towards antiviral polymer composites to combat COVID‐19 transmission
por: Mouritz, Adrian P., et al.
Publicado: (2021)

Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic
por: Marzo-Ortega, Helena, et al.
Publicado: (2020)

Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases
por: Sharma, Abhinav, et al.
Publicado: (2022)

The Rheumatic Diseases
Publicado: (1905)

What about rheumatic diseases and COVID-19?
por: Aouissi, H.A., et al.
Publicado: (2021)

Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
por: Yousefghahari, Behnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9jt311s8oe2a0aac7jnk4rcgv